Lexeo Therapeutics, Inc. Common Stock (LXEO) is a publicly traded Healthcare sector company. As of September 22, 2026, LXEO trades at $4.23 with a market cap of $344.59M and a P/E ratio of -2.19. LXEO moved +3.58% today. Year to date, LXEO is -58.91%; over the trailing twelve months it is -20.78%. Its 52-week range spans $1.45 to $10.99. Analyst consensus is strong buy with an average price target of $15.33. Rallies surfaces LXEO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest LXEO news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.23 |
| Market Cap | $344.59M |
| P/E Ratio | -2.19 |
| EPS | $-1.86 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.99 |
| 52-Week Low | $1.45 |
| Volume | 149.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-99.96M |
| Gross Margin | 0.00% |
3 analysts cover LXEO: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.33.